{"id":344,"date":"2016-04-19T14:59:41","date_gmt":"2016-04-19T13:59:41","guid":{"rendered":"http:\/\/localhost\/sopenet\/2016\/04\/19\/the-broken-clinical-trials-ecosystem\/"},"modified":"2016-04-19T14:59:41","modified_gmt":"2016-04-19T13:59:41","slug":"the-broken-clinical-trials-ecosystem","status":"publish","type":"post","link":"https:\/\/sopenet.org\/id\/the-broken-clinical-trials-ecosystem\/","title":{"rendered":"The Broken Clinical Trials Ecosystem"},"content":{"rendered":"<p><span style=\"font-family: Arial, Helvetica, sans-serif; font-size: 12px;\">Testing your product in humans to demonstrate its safety and effectiveness is a critical step in getting regulatory approval, investor interest, and customer-patients. The clinical trial system for biopharma and medtech, however, has several flaws, and, for digital health, is virtually non-existent.&nbsp; &#8211; See more at: <a href=\"http:\/\/www.hcplive.com\/physicians-money-digest\/contributor\/arlen-meyers-md-mba\/2016\/04\/the-broken-clinical-trials-ecosystem#sthash.6Ij1nZ23.dpuf\">http:\/\/www.hcplive.com\/physicians-money-digest\/contributor\/arlen-meyers-md-mba\/2016\/04\/the-broken-clinical-trials-ecosystem#sthash.6Ij1nZ23.dpuf<\/a><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Testing your product in humans to demonstrate its safety and effectiveness is a critical step in getting regulatory approval, investor interest, and customer-patients. The clinical trial system for biopharma and medtech, however, has several flaws, and, for digital health, is virtually non-existent.&nbsp; &#8211; See more at: http:\/\/www.hcplive.com\/physicians-money-digest\/contributor\/arlen-meyers-md-mba\/2016\/04\/the-broken-clinical-trials-ecosystem#sthash.6Ij1nZ23.dpuf<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[],"class_list":["post-344","post","type-post","status-publish","format-standard","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/sopenet.org\/id\/wp-json\/wp\/v2\/posts\/344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sopenet.org\/id\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sopenet.org\/id\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sopenet.org\/id\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sopenet.org\/id\/wp-json\/wp\/v2\/comments?post=344"}],"version-history":[{"count":0,"href":"https:\/\/sopenet.org\/id\/wp-json\/wp\/v2\/posts\/344\/revisions"}],"wp:attachment":[{"href":"https:\/\/sopenet.org\/id\/wp-json\/wp\/v2\/media?parent=344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sopenet.org\/id\/wp-json\/wp\/v2\/categories?post=344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sopenet.org\/id\/wp-json\/wp\/v2\/tags?post=344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}